Understanding how HIV care impacts older adults in the U.S.
PEARL 2.0: The impact of the Ending the HIV Epidemic initiative and risk factor interventions on the projected multimorbidity burden and healthcare costs for people aging with HIV in the United States
This study looks at how different health programs can help older adults living with HIV in the U.S. by improving their health and lowering healthcare costs, so that doctors and policymakers can better support their needs as they age.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10886848 on NIH RePORTER |
What this research studies
This research investigates the future healthcare needs of older adults living with HIV in the United States, particularly focusing on how interventions aimed at ending the HIV epidemic will affect their health and healthcare costs. By using a computer simulation model, the study will analyze various scenarios to project the impact of reducing risk factors like smoking and obesity on the health of this population. The goal is to provide valuable insights for healthcare policymakers and providers to better allocate resources and improve care for aging individuals with HIV.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults aged 21 and above who are living with HIV and receiving antiretroviral therapy.
Not a fit: Patients who are not living with HIV or are under the age of 21 may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved healthcare strategies that enhance the quality of life and reduce healthcare costs for older adults living with HIV.
How similar studies have performed: Previous research has shown success in using simulation models to project healthcare needs and costs for various populations, indicating that this approach is promising.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Althoff, Keri Nicole — Johns Hopkins University
- Study coordinator: Althoff, Keri Nicole
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.